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Background: Development of aortic insufficiency (AI) with continuous flow left ventricular assist device (LVAD) therapy is one of the most 
significant issues in mechanical circulatory support. The longitudinal trajectory, mechanisms and associated effects have not been fully determined.
methods: We analyzed data from 96 patients who underwent continuous flow LVAD implantation at a single academic center between November 
2005 and July 2012. LVADs included 81 HeartMate II, 13 HeartWare, and 2 VentrAssist. Preoperative AI grade was classified into 3 groups (none: 
54, trace: 25, and mild: 17). De novo AI was defined as the development of mild or greater AI in patients with none or trace preoperative AI. We 
evaluated the longitudinal differences between the de novo AI group and no AI group at 1, 3, 7 and 12 months after LVAD implantation.
results: Except 2+ preoperative AI group, a significant increase of AI was found, with the most rapid development seen in the preoperative no 
AI group. De novo AI was observed in 42 patients. Compared to patients who did not develop AI, the de novo AI group had a greater percentage of 
patients with no opening of the aortic valve at 3 months (26 of 39, 67%, vs 11 of 31, 35%, P = 0.009) and 7 months (15 of 22, 68%, vs 7 of 19, 
37%, P = 0.043) follow-up. LV end-diastolic dimension (LVDd), LV end-systolic dimension, mitral regurgitation and pulmonary artery systolic pressure 
(PASP) significantly decreased in all patients. In patients with no AI, LV ejection fraction increased and left atrial dimension (LAD) also decreased 
significantly (P = 0.015 and 0.005, respectively). In a subset of patients followed for > 12 months (n = 25), there were trends toward increases in 
the rate of change of LV diastolic and aortic diameters, LAD and PASP between preoperative and 1 year in those without AI (P = 0.060, 0.055, 0.085 
and 0.080, respectively).
conclusion: Under continuous flow LVAD support, absence of preoperative AI did not correlate with reduced risk for AI development. De novo AI 
was seen more often in patients without aortic valve opening. In patients without de novo AI, there were long-term trends toward enlarged aortic root 
diameter.
